Testing an IV stem cell treatment for idiopathic pulmonary fibrosis
Treatments studied
Part of Lungs & breathing clinical trials.
This Phase 1 study tests whether an IV infusion of stem cells from donated umbilical cord tissue is safe for people with idiopathic pulmonary fibrosis. It focuses mainly on safety and tolerability, and it may help by offering a new treatment approach if the cells are safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with idiopathic pulmonary fibrosis (scarring of the lungs with no known cause)
- You understand the study and are willing to sign informed consent
- You do not have an active infection at the time of screening
- You do not have active cancer
- You are not pregnant (and pregnancy must be avoided during the study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests whether donor stem cells made from umbilical cord tissue are safe in people with lung diseases. If you qualify, you may be offered the study treatment while the team closely checks for side effects and safety.
This early study (Phase 1) tests whether an intravenously given, donated stem cell product is safe for people with chronic kidney disease. It mainly looks at side effects and whether the treatment can be given without harming you.
This Phase 1 trial tests whether an IV infusion of donated (allogeneic) stem cells is safe in people with Crohn’s disease or ulcerative colitis. It focuses mainly on safety and tolerability, and it may offer a new treatment approach if you qualify.
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
This trial tests whether an IV infusion of lab-made donor stem cells is safe for people with autism. It mainly looks at side effects and whether the treatment can be given without causing harm.
This early safety study tests whether an intravenous (through a vein) stem cell product made from donated umbilical cord cells is safe for people with systemic sclerosis. If you join, the goal is to see how your body tolerates the treatment and monitor for side effects.
Hear when a new Idiopathic Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.